Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 24.20
-0.20 (-0.82%)
Aug 26, 2026, 4:01 PM CET
Nordhealth AS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 48.55 | 45.65 | 40.2 | 33.09 | 28.22 | 18.46 |
Other Revenue | 4.59 | 5.19 | 5.48 | 3.74 | 2.83 | 1.84 |
| 53.14 | 50.84 | 45.68 | 36.83 | 31.05 | 20.3 | |
Revenue Growth | 9.20% | 11.31% | 24.03% | 18.60% | 52.96% | 60.04% |
Cost of Revenue | 40.62 | 37.3 | 30.01 | 27.66 | 27.04 | 13.64 |
Gross Profit | 12.52 | 13.54 | 15.67 | 9.16 | 4.01 | 6.67 |
Selling, General & Admin | 2 | 2.15 | 2.38 | 2.59 | 2.76 | 1.12 |
Amortization of Goodwill & Intangibles | 6.42 | 6.29 | 6.31 | 6.44 | 6.47 | 2.93 |
Other Operating Expenses | 12.93 | 12.58 | 10.2 | 7.82 | 7.23 | 5.77 |
Operating Expenses | 27.64 | 26.01 | 23.39 | 20.55 | 18.69 | 11.12 |
Operating Income | -15.12 | -12.47 | -7.73 | -11.39 | -14.68 | -4.46 |
Interest Expense | -0.11 | -0.04 | -0.04 | -0.01 | -0.02 | -0.04 |
Interest & Investment Income | - | 0.07 | 0.22 | 0.15 | 0.11 | - |
Currency Exchange Gain (Loss) | -0.32 | -0.32 | 0.12 | -0.26 | 0.46 | -0.15 |
Other Non Operating Income (Expenses) | 0.21 | 0.48 | 0.78 | 0.7 | 0 | - |
EBT Excluding Unusual Items | -15.34 | -12.29 | -6.64 | -10.81 | -14.13 | -4.65 |
Pretax Income | -15.34 | -12.29 | -6.64 | -10.81 | -14.13 | -4.65 |
Income Tax Expense | 0.57 | 0.39 | 1.04 | 0.33 | 0.14 | 0.09 |
Net Income | -15.91 | -12.68 | -7.67 | -11.13 | -14.26 | -4.73 |
Net Income to Common | -15.91 | -12.68 | -7.67 | -11.13 | -14.26 | -4.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 79 | 79 | 79 | - | 80 | 80 |
Shares Outstanding (Diluted) | 79 | 79 | 79 | - | 80 | 80 |
Shares Change | -0.27% | -0.32% | - | - | 0.24% | - |
EPS (Basic) | -0.20 | -0.16 | -0.10 | - | -0.18 | -0.06 |
EPS (Diluted) | -0.20 | -0.16 | -0.10 | - | -0.18 | -0.06 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.3 | -4.37 | -3.17 | -10.95 | -13.1 | 2.19 |
Free Cash Flow Per Share | -0.09 | -0.06 | -0.04 | - | -0.16 | 0.03 |
Gross Margin | 23.57% | 26.63% | 34.30% | 24.88% | 12.93% | 32.83% |
Operating Margin | -28.45% | -24.53% | -16.91% | -30.92% | -47.27% | -21.96% |
Profit Margin | -29.94% | -24.94% | -16.80% | -30.23% | -45.94% | -23.30% |
Free Cash Flow Margin | -13.74% | -8.60% | -6.94% | -29.72% | -42.20% | 10.79% |
EBITDA | -10.51 | -5.77 | 3.09 | -1.25 | -5.98 | -0.22 |
EBITDA Margin | -19.78% | -11.35% | 6.76% | -3.39% | -19.24% | -1.09% |
D&A For EBITDA | 4.61 | 6.7 | 10.81 | 10.14 | 8.7 | 4.24 |
EBIT | -15.12 | -12.47 | -7.73 | -11.39 | -14.68 | -4.46 |
EBIT Margin | -28.45% | -24.53% | -16.91% | -30.92% | -47.27% | -21.96% |
Revenue as Reported | 53.36 | 51.08 | 45.81 | 36.83 | 31.05 | 20.3 |